Can alkaline phosphatase be elevated in a 20-year-old woman receiving depot medroxyprogesterone acetate (Depo‑Provera)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can ALP be elevated in a 20-year-old woman receiving Depo-Provera?

Yes, alkaline phosphatase (ALP) can be elevated in a 20-year-old woman receiving depot medroxyprogesterone acetate (Depo-Provera), though this is typically a benign finding related to bone turnover rather than liver pathology.

Understanding ALP Elevation in Young Women on Depo-Provera

Physiologic Context

ALP levels are physiologically higher in young adults due to ongoing bone growth and remodeling 1. In a 20-year-old woman, bone-derived ALP is the predominant source, as peak bone mass acquisition continues into the mid-20s. This baseline elevation is normal and expected.

Evidence from Depo-Provera Studies

Research specifically examining metabolic effects of DMPA has documented elevated alkaline phosphatase levels in long-term users 2. A cross-sectional study of 57 Thai women using DMPA for ≥5 years found significantly higher alkaline phosphatase levels compared to non-users, alongside elevated insulin and cortisol levels 2.

However, other studies provide reassuring context:

  • Multiple investigations found no changes in liver function tests (including ALP) during DMPA use 3, 4
  • One study in undernourished lactating women actually showed a fall in alkaline phosphatase activity over one year of DMPA use, attributed to decreased bone turnover as lactation waned 5
  • High-dose MPA studies showed no changes in alkaline phosphatase levels 6

Distinguishing Bone vs. Liver Source

The critical clinical question is determining whether elevated ALP originates from bone or liver 1, 7:

Order these tests to differentiate:

  • GGT (gamma-glutamyl transferase): If normal, ALP is likely bone-derived; if elevated proportionately with ALP, suggests hepatic cholestasis 1, 7
  • 5'-nucleotidase: Elevations indicate hepatobiliary disease 7
  • ALP isoenzyme fractionation: Directly identifies liver vs. bone vs. intestinal sources 7
  • Bone turnover markers (BAP, bone-specific ALP): Elevated in high bone turnover states 8

Clinical Approach

In a healthy 20-year-old on Depo-Provera with isolated ALP elevation:

  1. Check GGT first - this is the most practical initial test

    • If GGT is normal → bone source is likely, no further workup needed
    • If GGT is elevated → proceed with comprehensive hepatobiliary evaluation
  2. Review for other causes of bone-derived ALP elevation:

    • Recent fracture
    • Vitamin D deficiency (common in young women)
    • Hyperparathyroidism
    • Other bone disorders
  3. Assess for hepatobiliary disease only if indicated:

    • Check ALT, AST, total and direct bilirubin
    • Review medications for drug-induced cholestasis 1
    • Consider imaging if cholestatic pattern confirmed

Key Clinical Pitfalls

Do not automatically attribute ALP elevation to liver pathology in young women - bone is the most common source in this age group 1, 8. The evidence suggests DMPA may cause mild ALP elevations through effects on bone metabolism or insulin resistance 2, but this does not represent hepatotoxicity.

Do not discontinue Depo-Provera based solely on isolated ALP elevation without confirming hepatic origin. The FDA label for Depo-Provera does not list hepatotoxicity or ALP elevation as a contraindication or warning 9.

Bottom Line

An isolated ALP elevation in a 20-year-old woman on Depo-Provera is most likely physiologic or bone-derived rather than representing drug-induced liver injury. Confirm the source with GGT testing before pursuing extensive hepatobiliary workup. The available evidence does not support discontinuing DMPA for isolated ALP elevation in the absence of confirmed liver disease.

Related Questions

For a 35-year-old woman with hypertension (blood pressure 167/87 mm Hg), who smokes cigarettes and uses marijuana, has irregular menstrual periods, and needs a refill of depot medroxyprogesterone acetate (DMPA) injection, what is the appropriate contraceptive management?
For a 50-year-old woman receiving her scheduled Depo‑Provera injection who has been off sertraline 50 mg and buspirone 15 mg for about five weeks, can both medications be restarted simultaneously, and what initial dosing should be used?
What is the next step in evaluating a 70-year-old woman with progressively elevated alkaline phosphatase (ALP) levels, normal liver ultrasound, and normal calcium and phosphate levels to rule out bone metastasis?
What is the treatment for elevated alkaline phosphatase and low ferritin?
Can a 28-year-old woman who has been using depot medroxyprogesterone acetate (Depo‑Provera) for three years switch to a combined oral contraceptive pill?
After successful defibrillation of pulseless ventricular tachycardia during CPR with return of spontaneous circulation, the patient is now in sinus rhythm on norepinephrine support; should an antiarrhythmic such as amiodarone or a β‑blocker be administered?
What are the clinical symptoms of fifth disease (erythema infectiosum)?
Can anti‑D immunoglobulin (Rhogam) be administered to an Rh‑negative pregnant woman beyond 34 weeks gestation?
Is ketamine an appropriate rescue treatment for refractory cluster headache or migraine in adults?
In an elderly patient with Alzheimer disease taking donepezil, should the medication be continued on the day of surgery and what anesthesia precautions are recommended?
What are the positive clinical and imaging findings that indicate a serious underlying condition in a patient with severe hip pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.